Most Recent
Swiss pharmaceutical company Biogen is seeking a court order blocking an Australian generic drug manufacturer from selling a cheap multiple sclerosis drug it claims infringes its patent for medicine Tecfidera, a court has heard.
A New Zealand-based association representing manuka honey beekeepers has lost its opposition to an application for the ‘Australian Manuka’ trade mark by a Byron Bay honey producer, with IP Australia finding the word ‘manuka’ did not specifically refer to honey made in NZ.